nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—ABCB1—ovarian cancer	0.255	1	CbGaD
Ciprofloxacin—TOP2A—Epirubicin—ovarian cancer	0.128	0.249	CbGbCtD
Ciprofloxacin—TOP2A—Doxorubicin—ovarian cancer	0.0679	0.132	CbGbCtD
Ciprofloxacin—CYP3A7—Paclitaxel—ovarian cancer	0.0345	0.0673	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0345	0.0673	CbGbCtD
Ciprofloxacin—ABCB1—Topotecan—ovarian cancer	0.034	0.0664	CbGbCtD
Ciprofloxacin—CYP3A5—Paclitaxel—ovarian cancer	0.0259	0.0505	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0249	0.0486	CbGbCtD
Ciprofloxacin—CYP3A7—Docetaxel—ovarian cancer	0.0249	0.0486	CbGbCtD
Ciprofloxacin—ABCB1—Vinorelbine—ovarian cancer	0.024	0.0468	CbGbCtD
Ciprofloxacin—CYP3A4—Topotecan—ovarian cancer	0.0204	0.0398	CbGbCtD
Ciprofloxacin—CYP3A5—Docetaxel—ovarian cancer	0.0187	0.0365	CbGbCtD
Ciprofloxacin—ABCB1—Paclitaxel—ovarian cancer	0.0168	0.0329	CbGbCtD
Ciprofloxacin—CYP3A4—Vinorelbine—ovarian cancer	0.0144	0.028	CbGbCtD
Ciprofloxacin—ABCB1—Docetaxel—ovarian cancer	0.0122	0.0238	CbGbCtD
Ciprofloxacin—CYP3A4—Paclitaxel—ovarian cancer	0.0101	0.0197	CbGbCtD
Ciprofloxacin—ABCB1—Doxorubicin—ovarian cancer	0.00908	0.0177	CbGbCtD
Ciprofloxacin—CYP3A4—Docetaxel—ovarian cancer	0.0073	0.0142	CbGbCtD
Ciprofloxacin—CYP3A4—Doxorubicin—ovarian cancer	0.00544	0.0106	CbGbCtD
Ciprofloxacin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.00103	0.219	CbGdCrCtD
Ciprofloxacin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000882	0.187	CbGdCrCtD
Ciprofloxacin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.000655	0.139	CbGdCrCtD
Ciprofloxacin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000514	0.109	CbGdCrCtD
Ciprofloxacin—TOP2A—myometrium—ovarian cancer	0.000365	0.104	CbGeAlD
Ciprofloxacin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000354	0.075	CbGdCrCtD
Ciprofloxacin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000284	0.0603	CbGdCrCtD
Ciprofloxacin—TOP2A—uterine cervix—ovarian cancer	0.000284	0.0808	CbGeAlD
Ciprofloxacin—TOP2A—decidua—ovarian cancer	0.000271	0.077	CbGeAlD
Ciprofloxacin—TOP2A—endometrium—ovarian cancer	0.000257	0.0731	CbGeAlD
Ciprofloxacin—TOP2A—uterus—ovarian cancer	0.000237	0.0674	CbGeAlD
Ciprofloxacin—TOP2A—bone marrow—ovarian cancer	0.000201	0.0572	CbGeAlD
Ciprofloxacin—TOP2A—female gonad—ovarian cancer	0.000194	0.0551	CbGeAlD
Ciprofloxacin—TOP2A—vagina—ovarian cancer	0.000193	0.0548	CbGeAlD
Ciprofloxacin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.000172	0.0365	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.000172	0.0365	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.000172	0.0365	CbGdCrCtD
Ciprofloxacin—TOP2A—testis—ovarian cancer	0.000172	0.0489	CbGeAlD
Ciprofloxacin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000159	0.0338	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000159	0.0338	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000159	0.0338	CbGdCrCtD
Ciprofloxacin—CYP3A5—uterine cervix—ovarian cancer	0.000132	0.0374	CbGeAlD
Ciprofloxacin—TOP2A—lymph node—ovarian cancer	0.000125	0.0354	CbGeAlD
Ciprofloxacin—ABCB1—myometrium—ovarian cancer	8.98e-05	0.0255	CbGeAlD
Ciprofloxacin—CYP3A5—female gonad—ovarian cancer	8.97e-05	0.0255	CbGeAlD
Ciprofloxacin—CYP3A5—vagina—ovarian cancer	8.91e-05	0.0253	CbGeAlD
Ciprofloxacin—ABCB1—embryo—ovarian cancer	8.64e-05	0.0246	CbGeAlD
Ciprofloxacin—CYP3A4—female reproductive system—ovarian cancer	7.4e-05	0.021	CbGeAlD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—ovarian cancer	7.37e-05	0.00588	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—ovarian cancer	7.33e-05	0.00585	CbGpPWpGaD
Ciprofloxacin—ABCB1—epithelium—ovarian cancer	7.05e-05	0.02	CbGeAlD
Ciprofloxacin—ABCB1—uterine cervix—ovarian cancer	6.99e-05	0.0199	CbGeAlD
Ciprofloxacin—Constipation—Paclitaxel—ovarian cancer	6.98e-05	0.00033	CcSEcCtD
Ciprofloxacin—Haematuria—Epirubicin—ovarian cancer	6.98e-05	0.00033	CcSEcCtD
Ciprofloxacin—Confusional state—Docetaxel—ovarian cancer	6.98e-05	0.00033	CcSEcCtD
Ciprofloxacin—Photosensitivity reaction—Doxorubicin—ovarian cancer	6.93e-05	0.000328	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Epirubicin—ovarian cancer	6.92e-05	0.000328	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Docetaxel—ovarian cancer	6.92e-05	0.000328	CcSEcCtD
Ciprofloxacin—Oedema—Docetaxel—ovarian cancer	6.92e-05	0.000328	CcSEcCtD
Ciprofloxacin—Epistaxis—Epirubicin—ovarian cancer	6.9e-05	0.000327	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	6.88e-05	0.0055	CbGpPWpGaD
Ciprofloxacin—Hyperglycaemia—Doxorubicin—ovarian cancer	6.85e-05	0.000324	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Epirubicin—ovarian cancer	6.83e-05	0.000323	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—RAD51C—ovarian cancer	6.82e-05	0.00545	CbGpPWpGaD
Ciprofloxacin—Pneumonia—Doxorubicin—ovarian cancer	6.81e-05	0.000322	CcSEcCtD
Ciprofloxacin—Shock—Docetaxel—ovarian cancer	6.81e-05	0.000322	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Docetaxel—ovarian cancer	6.79e-05	0.000321	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Docetaxel—ovarian cancer	6.77e-05	0.000321	CcSEcCtD
Ciprofloxacin—Infestation—Doxorubicin—ovarian cancer	6.77e-05	0.000321	CcSEcCtD
Ciprofloxacin—Drowsiness—Doxorubicin—ovarian cancer	6.77e-05	0.000321	CcSEcCtD
Ciprofloxacin—Infestation NOS—Doxorubicin—ovarian cancer	6.77e-05	0.000321	CcSEcCtD
Ciprofloxacin—Tachycardia—Docetaxel—ovarian cancer	6.75e-05	0.00032	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Paclitaxel—ovarian cancer	6.73e-05	0.000318	CcSEcCtD
Ciprofloxacin—Skin disorder—Docetaxel—ovarian cancer	6.72e-05	0.000318	CcSEcCtD
Ciprofloxacin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	6.71e-05	0.000318	CcSEcCtD
Ciprofloxacin—Bradycardia—Epirubicin—ovarian cancer	6.69e-05	0.000317	CcSEcCtD
Ciprofloxacin—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	6.68e-05	0.00534	CbGpPWpGaD
Ciprofloxacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.68e-05	0.000316	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	6.67e-05	0.00533	CbGpPWpGaD
Ciprofloxacin—ABCB1—decidua—ovarian cancer	6.66e-05	0.0189	CbGeAlD
Ciprofloxacin—Renal failure—Doxorubicin—ovarian cancer	6.66e-05	0.000315	CcSEcCtD
Ciprofloxacin—Neuropathy peripheral—Doxorubicin—ovarian cancer	6.64e-05	0.000314	CcSEcCtD
Ciprofloxacin—Haemoglobin—Epirubicin—ovarian cancer	6.6e-05	0.000313	CcSEcCtD
Ciprofloxacin—Stomatitis—Doxorubicin—ovarian cancer	6.6e-05	0.000312	CcSEcCtD
Ciprofloxacin—Jaundice—Doxorubicin—ovarian cancer	6.6e-05	0.000312	CcSEcCtD
Ciprofloxacin—Anorexia—Docetaxel—ovarian cancer	6.6e-05	0.000312	CcSEcCtD
Ciprofloxacin—Rhinitis—Epirubicin—ovarian cancer	6.59e-05	0.000312	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Doxorubicin—ovarian cancer	6.58e-05	0.000312	CcSEcCtD
Ciprofloxacin—Hepatitis—Epirubicin—ovarian cancer	6.57e-05	0.000311	CcSEcCtD
Ciprofloxacin—Haemorrhage—Epirubicin—ovarian cancer	6.57e-05	0.000311	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Epirubicin—ovarian cancer	6.54e-05	0.000309	CcSEcCtD
Ciprofloxacin—Pharyngitis—Epirubicin—ovarian cancer	6.52e-05	0.000309	CcSEcCtD
Ciprofloxacin—Sweating—Doxorubicin—ovarian cancer	6.49e-05	0.000307	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Epirubicin—ovarian cancer	6.49e-05	0.000307	CcSEcCtD
Ciprofloxacin—Urticaria—Paclitaxel—ovarian cancer	6.48e-05	0.000307	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Epirubicin—ovarian cancer	6.47e-05	0.000306	CcSEcCtD
Ciprofloxacin—Hypotension—Docetaxel—ovarian cancer	6.47e-05	0.000306	CcSEcCtD
Ciprofloxacin—Haematuria—Doxorubicin—ovarian cancer	6.46e-05	0.000306	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Epirubicin—ovarian cancer	6.46e-05	0.000306	CcSEcCtD
Ciprofloxacin—Abdominal pain—Paclitaxel—ovarian cancer	6.45e-05	0.000306	CcSEcCtD
Ciprofloxacin—Body temperature increased—Paclitaxel—ovarian cancer	6.45e-05	0.000306	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	6.45e-05	0.00515	CbGpPWpGaD
Ciprofloxacin—Urethral disorder—Epirubicin—ovarian cancer	6.44e-05	0.000305	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Doxorubicin—ovarian cancer	6.4e-05	0.000303	CcSEcCtD
Ciprofloxacin—Epistaxis—Doxorubicin—ovarian cancer	6.39e-05	0.000302	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	6.37e-05	0.00508	CbGpPWpGaD
Ciprofloxacin—Visual impairment—Epirubicin—ovarian cancer	6.33e-05	0.0003	CcSEcCtD
Ciprofloxacin—ABCB1—endometrium—ovarian cancer	6.32e-05	0.018	CbGeAlD
Ciprofloxacin—Agranulocytosis—Doxorubicin—ovarian cancer	6.32e-05	0.000299	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.3e-05	0.000298	CcSEcCtD
Ciprofloxacin—Insomnia—Docetaxel—ovarian cancer	6.26e-05	0.000296	CcSEcCtD
Ciprofloxacin—Paraesthesia—Docetaxel—ovarian cancer	6.21e-05	0.000294	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Epirubicin—ovarian cancer	6.21e-05	0.000294	CcSEcCtD
Ciprofloxacin—Bradycardia—Doxorubicin—ovarian cancer	6.19e-05	0.000293	CcSEcCtD
Ciprofloxacin—Dyspnoea—Docetaxel—ovarian cancer	6.17e-05	0.000292	CcSEcCtD
Ciprofloxacin—Somnolence—Docetaxel—ovarian cancer	6.15e-05	0.000291	CcSEcCtD
Ciprofloxacin—Eye disorder—Epirubicin—ovarian cancer	6.14e-05	0.000291	CcSEcCtD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	6.13e-05	0.00489	CbGpPWpGaD
Ciprofloxacin—Tinnitus—Epirubicin—ovarian cancer	6.12e-05	0.00029	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ovarian cancer	6.12e-05	0.00489	CbGpPWpGaD
Ciprofloxacin—Haemoglobin—Doxorubicin—ovarian cancer	6.11e-05	0.000289	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Epirubicin—ovarian cancer	6.1e-05	0.000289	CcSEcCtD
Ciprofloxacin—Flushing—Epirubicin—ovarian cancer	6.1e-05	0.000289	CcSEcCtD
Ciprofloxacin—Rhinitis—Doxorubicin—ovarian cancer	6.09e-05	0.000288	CcSEcCtD
Ciprofloxacin—Dyspepsia—Docetaxel—ovarian cancer	6.09e-05	0.000288	CcSEcCtD
Ciprofloxacin—Hepatitis—Doxorubicin—ovarian cancer	6.08e-05	0.000288	CcSEcCtD
Ciprofloxacin—Haemorrhage—Doxorubicin—ovarian cancer	6.08e-05	0.000288	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Doxorubicin—ovarian cancer	6.05e-05	0.000286	CcSEcCtD
Ciprofloxacin—Pharyngitis—Doxorubicin—ovarian cancer	6.03e-05	0.000286	CcSEcCtD
Ciprofloxacin—Decreased appetite—Docetaxel—ovarian cancer	6.01e-05	0.000285	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Paclitaxel—ovarian cancer	6.01e-05	0.000285	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Doxorubicin—ovarian cancer	6e-05	0.000284	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Doxorubicin—ovarian cancer	5.99e-05	0.000283	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Docetaxel—ovarian cancer	5.97e-05	0.000283	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Doxorubicin—ovarian cancer	5.97e-05	0.000283	CcSEcCtD
Ciprofloxacin—Fatigue—Docetaxel—ovarian cancer	5.97e-05	0.000282	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—PPP1CC—ovarian cancer	5.96e-05	0.00476	CbGpPWpGaD
Ciprofloxacin—Angiopathy—Epirubicin—ovarian cancer	5.96e-05	0.000282	CcSEcCtD
Ciprofloxacin—Urethral disorder—Doxorubicin—ovarian cancer	5.96e-05	0.000282	CcSEcCtD
Ciprofloxacin—Immune system disorder—Epirubicin—ovarian cancer	5.93e-05	0.000281	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Epirubicin—ovarian cancer	5.92e-05	0.00028	CcSEcCtD
Ciprofloxacin—Constipation—Docetaxel—ovarian cancer	5.92e-05	0.00028	CcSEcCtD
Ciprofloxacin—Pain—Docetaxel—ovarian cancer	5.92e-05	0.00028	CcSEcCtD
Ciprofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	5.91e-05	0.00472	CbGpPWpGaD
Ciprofloxacin—Chills—Epirubicin—ovarian cancer	5.89e-05	0.000279	CcSEcCtD
Ciprofloxacin—Arrhythmia—Epirubicin—ovarian cancer	5.87e-05	0.000278	CcSEcCtD
Ciprofloxacin—ABCB1—gonad—ovarian cancer	5.86e-05	0.0167	CbGeAlD
Ciprofloxacin—Visual impairment—Doxorubicin—ovarian cancer	5.86e-05	0.000277	CcSEcCtD
Ciprofloxacin—Asthenia—Paclitaxel—ovarian cancer	5.86e-05	0.000277	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	5.83e-05	0.00466	CbGpPWpGaD
Ciprofloxacin—ABCB1—uterus—ovarian cancer	5.82e-05	0.0166	CbGeAlD
Ciprofloxacin—Alopecia—Epirubicin—ovarian cancer	5.8e-05	0.000275	CcSEcCtD
Ciprofloxacin—Pruritus—Paclitaxel—ovarian cancer	5.78e-05	0.000273	CcSEcCtD
Ciprofloxacin—Mental disorder—Epirubicin—ovarian cancer	5.75e-05	0.000272	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Doxorubicin—ovarian cancer	5.75e-05	0.000272	CcSEcCtD
Ciprofloxacin—Malnutrition—Epirubicin—ovarian cancer	5.72e-05	0.000271	CcSEcCtD
Ciprofloxacin—Erythema—Epirubicin—ovarian cancer	5.72e-05	0.000271	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Docetaxel—ovarian cancer	5.7e-05	0.00027	CcSEcCtD
Ciprofloxacin—Eye disorder—Doxorubicin—ovarian cancer	5.68e-05	0.000269	CcSEcCtD
Ciprofloxacin—Tinnitus—Doxorubicin—ovarian cancer	5.67e-05	0.000268	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Docetaxel—ovarian cancer	5.66e-05	0.000268	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	5.65e-05	0.00451	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	5.65e-05	0.00451	CbGpPWpGaD
Ciprofloxacin—Flushing—Doxorubicin—ovarian cancer	5.64e-05	0.000267	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Doxorubicin—ovarian cancer	5.64e-05	0.000267	CcSEcCtD
Ciprofloxacin—Flatulence—Epirubicin—ovarian cancer	5.63e-05	0.000267	CcSEcCtD
Ciprofloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	5.63e-05	0.0045	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	5.63e-05	0.0045	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	5.63e-05	0.0045	CbGpPWpGaD
Ciprofloxacin—Tension—Epirubicin—ovarian cancer	5.61e-05	0.000266	CcSEcCtD
Ciprofloxacin—Dysgeusia—Epirubicin—ovarian cancer	5.6e-05	0.000265	CcSEcCtD
Ciprofloxacin—Diarrhoea—Paclitaxel—ovarian cancer	5.59e-05	0.000264	CcSEcCtD
Ciprofloxacin—Nervousness—Epirubicin—ovarian cancer	5.55e-05	0.000263	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	5.55e-05	0.00443	CbGpPWpGaD
Ciprofloxacin—Back pain—Epirubicin—ovarian cancer	5.53e-05	0.000262	CcSEcCtD
Ciprofloxacin—Angiopathy—Doxorubicin—ovarian cancer	5.51e-05	0.000261	CcSEcCtD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	5.51e-05	0.0044	CbGpPWpGaD
Ciprofloxacin—Muscle spasms—Epirubicin—ovarian cancer	5.5e-05	0.00026	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	5.49e-05	0.00439	CbGpPWpGaD
Ciprofloxacin—Immune system disorder—Doxorubicin—ovarian cancer	5.49e-05	0.00026	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Doxorubicin—ovarian cancer	5.48e-05	0.000259	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—RBL2—ovarian cancer	5.48e-05	0.00437	CbGpPWpGaD
Ciprofloxacin—Abdominal pain—Docetaxel—ovarian cancer	5.47e-05	0.000259	CcSEcCtD
Ciprofloxacin—Body temperature increased—Docetaxel—ovarian cancer	5.47e-05	0.000259	CcSEcCtD
Ciprofloxacin—Chills—Doxorubicin—ovarian cancer	5.45e-05	0.000258	CcSEcCtD
Ciprofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	5.44e-05	0.00434	CbGpPWpGaD
Ciprofloxacin—Arrhythmia—Doxorubicin—ovarian cancer	5.43e-05	0.000257	CcSEcCtD
Ciprofloxacin—Dizziness—Paclitaxel—ovarian cancer	5.4e-05	0.000256	CcSEcCtD
Ciprofloxacin—Vision blurred—Epirubicin—ovarian cancer	5.39e-05	0.000255	CcSEcCtD
Ciprofloxacin—Alopecia—Doxorubicin—ovarian cancer	5.37e-05	0.000254	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	5.33e-05	0.00425	CbGpPWpGaD
Ciprofloxacin—Mental disorder—Doxorubicin—ovarian cancer	5.32e-05	0.000252	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Epirubicin—ovarian cancer	5.31e-05	0.000251	CcSEcCtD
Ciprofloxacin—Erythema—Doxorubicin—ovarian cancer	5.29e-05	0.00025	CcSEcCtD
Ciprofloxacin—Malnutrition—Doxorubicin—ovarian cancer	5.29e-05	0.00025	CcSEcCtD
Ciprofloxacin—Anaemia—Epirubicin—ovarian cancer	5.29e-05	0.00025	CcSEcCtD
Ciprofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	5.27e-05	0.00421	CbGpPWpGaD
Ciprofloxacin—Agitation—Epirubicin—ovarian cancer	5.25e-05	0.000249	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	5.24e-05	0.00418	CbGpPWpGaD
Ciprofloxacin—ABCB1—female reproductive system—ovarian cancer	5.24e-05	0.0149	CbGeAlD
Ciprofloxacin—Flatulence—Doxorubicin—ovarian cancer	5.21e-05	0.000247	CcSEcCtD
Ciprofloxacin—Tension—Doxorubicin—ovarian cancer	5.19e-05	0.000246	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	5.19e-05	0.00414	CbGpPWpGaD
Ciprofloxacin—Vomiting—Paclitaxel—ovarian cancer	5.19e-05	0.000246	CcSEcCtD
Ciprofloxacin—Dysgeusia—Doxorubicin—ovarian cancer	5.18e-05	0.000245	CcSEcCtD
Ciprofloxacin—Malaise—Epirubicin—ovarian cancer	5.16e-05	0.000244	CcSEcCtD
Ciprofloxacin—Rash—Paclitaxel—ovarian cancer	5.15e-05	0.000244	CcSEcCtD
Ciprofloxacin—Dermatitis—Paclitaxel—ovarian cancer	5.14e-05	0.000243	CcSEcCtD
Ciprofloxacin—Nervousness—Doxorubicin—ovarian cancer	5.14e-05	0.000243	CcSEcCtD
Ciprofloxacin—Vertigo—Epirubicin—ovarian cancer	5.14e-05	0.000243	CcSEcCtD
Ciprofloxacin—Syncope—Epirubicin—ovarian cancer	5.13e-05	0.000243	CcSEcCtD
Ciprofloxacin—Leukopenia—Epirubicin—ovarian cancer	5.12e-05	0.000242	CcSEcCtD
Ciprofloxacin—Back pain—Doxorubicin—ovarian cancer	5.12e-05	0.000242	CcSEcCtD
Ciprofloxacin—Headache—Paclitaxel—ovarian cancer	5.11e-05	0.000242	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Docetaxel—ovarian cancer	5.1e-05	0.000241	CcSEcCtD
Ciprofloxacin—Muscle spasms—Doxorubicin—ovarian cancer	5.09e-05	0.000241	CcSEcCtD
Ciprofloxacin—Palpitations—Epirubicin—ovarian cancer	5.05e-05	0.000239	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Epirubicin—ovarian cancer	5.03e-05	0.000238	CcSEcCtD
Ciprofloxacin—Cough—Epirubicin—ovarian cancer	4.99e-05	0.000236	CcSEcCtD
Ciprofloxacin—Vision blurred—Doxorubicin—ovarian cancer	4.99e-05	0.000236	CcSEcCtD
Ciprofloxacin—Asthenia—Docetaxel—ovarian cancer	4.96e-05	0.000235	CcSEcCtD
Ciprofloxacin—Convulsion—Epirubicin—ovarian cancer	4.95e-05	0.000235	CcSEcCtD
Ciprofloxacin—ABCB1—bone marrow—ovarian cancer	4.94e-05	0.0141	CbGeAlD
Ciprofloxacin—Hypertension—Epirubicin—ovarian cancer	4.94e-05	0.000234	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Doxorubicin—ovarian cancer	4.91e-05	0.000232	CcSEcCtD
Ciprofloxacin—Pruritus—Docetaxel—ovarian cancer	4.9e-05	0.000232	CcSEcCtD
Ciprofloxacin—Anaemia—Doxorubicin—ovarian cancer	4.89e-05	0.000232	CcSEcCtD
Ciprofloxacin—Myalgia—Epirubicin—ovarian cancer	4.87e-05	0.00023	CcSEcCtD
Ciprofloxacin—Chest pain—Epirubicin—ovarian cancer	4.87e-05	0.00023	CcSEcCtD
Ciprofloxacin—Arthralgia—Epirubicin—ovarian cancer	4.87e-05	0.00023	CcSEcCtD
Ciprofloxacin—Agitation—Doxorubicin—ovarian cancer	4.86e-05	0.00023	CcSEcCtD
Ciprofloxacin—Anxiety—Epirubicin—ovarian cancer	4.85e-05	0.00023	CcSEcCtD
Ciprofloxacin—Nausea—Paclitaxel—ovarian cancer	4.85e-05	0.00023	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	4.83e-05	0.000229	CcSEcCtD
Ciprofloxacin—Discomfort—Epirubicin—ovarian cancer	4.81e-05	0.000228	CcSEcCtD
Ciprofloxacin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	4.79e-05	0.00382	CbGpPWpGaD
Ciprofloxacin—Malaise—Doxorubicin—ovarian cancer	4.77e-05	0.000226	CcSEcCtD
Ciprofloxacin—ABCB1—female gonad—ovarian cancer	4.76e-05	0.0135	CbGeAlD
Ciprofloxacin—Dry mouth—Epirubicin—ovarian cancer	4.76e-05	0.000225	CcSEcCtD
Ciprofloxacin—Vertigo—Doxorubicin—ovarian cancer	4.75e-05	0.000225	CcSEcCtD
Ciprofloxacin—Syncope—Doxorubicin—ovarian cancer	4.74e-05	0.000225	CcSEcCtD
Ciprofloxacin—Leukopenia—Doxorubicin—ovarian cancer	4.74e-05	0.000224	CcSEcCtD
Ciprofloxacin—ABCB1—vagina—ovarian cancer	4.73e-05	0.0135	CbGeAlD
Ciprofloxacin—Diarrhoea—Docetaxel—ovarian cancer	4.73e-05	0.000224	CcSEcCtD
Ciprofloxacin—Confusional state—Epirubicin—ovarian cancer	4.71e-05	0.000223	CcSEcCtD
Ciprofloxacin—Palpitations—Doxorubicin—ovarian cancer	4.68e-05	0.000221	CcSEcCtD
Ciprofloxacin—Oedema—Epirubicin—ovarian cancer	4.67e-05	0.000221	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Epirubicin—ovarian cancer	4.67e-05	0.000221	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Doxorubicin—ovarian cancer	4.65e-05	0.00022	CcSEcCtD
Ciprofloxacin—Cough—Doxorubicin—ovarian cancer	4.62e-05	0.000219	CcSEcCtD
Ciprofloxacin—Shock—Epirubicin—ovarian cancer	4.59e-05	0.000217	CcSEcCtD
Ciprofloxacin—Convulsion—Doxorubicin—ovarian cancer	4.58e-05	0.000217	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Epirubicin—ovarian cancer	4.58e-05	0.000217	CcSEcCtD
Ciprofloxacin—Dizziness—Docetaxel—ovarian cancer	4.58e-05	0.000217	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Epirubicin—ovarian cancer	4.57e-05	0.000216	CcSEcCtD
Ciprofloxacin—Hypertension—Doxorubicin—ovarian cancer	4.57e-05	0.000216	CcSEcCtD
Ciprofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	4.56e-05	0.00364	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	4.55e-05	0.00364	CbGpPWpGaD
Ciprofloxacin—Tachycardia—Epirubicin—ovarian cancer	4.55e-05	0.000216	CcSEcCtD
Ciprofloxacin—Skin disorder—Epirubicin—ovarian cancer	4.53e-05	0.000215	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Epirubicin—ovarian cancer	4.51e-05	0.000214	CcSEcCtD
Ciprofloxacin—Chest pain—Doxorubicin—ovarian cancer	4.5e-05	0.000213	CcSEcCtD
Ciprofloxacin—Arthralgia—Doxorubicin—ovarian cancer	4.5e-05	0.000213	CcSEcCtD
Ciprofloxacin—Myalgia—Doxorubicin—ovarian cancer	4.5e-05	0.000213	CcSEcCtD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP1B1—ovarian cancer	4.5e-05	0.0036	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	4.5e-05	0.00359	CbGpPWpGaD
Ciprofloxacin—Anxiety—Doxorubicin—ovarian cancer	4.49e-05	0.000213	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.47e-05	0.000212	CcSEcCtD
Ciprofloxacin—Discomfort—Doxorubicin—ovarian cancer	4.45e-05	0.000211	CcSEcCtD
Ciprofloxacin—Anorexia—Epirubicin—ovarian cancer	4.45e-05	0.000211	CcSEcCtD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP1B1—ovarian cancer	4.44e-05	0.00355	CbGpPWpGaD
Ciprofloxacin—Dry mouth—Doxorubicin—ovarian cancer	4.41e-05	0.000209	CcSEcCtD
Ciprofloxacin—Vomiting—Docetaxel—ovarian cancer	4.4e-05	0.000208	CcSEcCtD
Ciprofloxacin—Rash—Docetaxel—ovarian cancer	4.36e-05	0.000207	CcSEcCtD
Ciprofloxacin—Hypotension—Epirubicin—ovarian cancer	4.36e-05	0.000206	CcSEcCtD
Ciprofloxacin—Dermatitis—Docetaxel—ovarian cancer	4.36e-05	0.000206	CcSEcCtD
Ciprofloxacin—Confusional state—Doxorubicin—ovarian cancer	4.35e-05	0.000206	CcSEcCtD
Ciprofloxacin—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	4.35e-05	0.00347	CbGpPWpGaD
Ciprofloxacin—Headache—Docetaxel—ovarian cancer	4.33e-05	0.000205	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Doxorubicin—ovarian cancer	4.32e-05	0.000204	CcSEcCtD
Ciprofloxacin—Oedema—Doxorubicin—ovarian cancer	4.32e-05	0.000204	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	4.31e-05	0.00344	CbGpPWpGaD
Ciprofloxacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.25e-05	0.000201	CcSEcCtD
Ciprofloxacin—Shock—Doxorubicin—ovarian cancer	4.25e-05	0.000201	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Doxorubicin—ovarian cancer	4.23e-05	0.0002	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Doxorubicin—ovarian cancer	4.23e-05	0.0002	CcSEcCtD
Ciprofloxacin—ABCB1—testis—ovarian cancer	4.23e-05	0.012	CbGeAlD
Ciprofloxacin—Insomnia—Epirubicin—ovarian cancer	4.22e-05	0.0002	CcSEcCtD
Ciprofloxacin—Tachycardia—Doxorubicin—ovarian cancer	4.21e-05	0.0002	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	4.2e-05	0.00336	CbGpPWpGaD
Ciprofloxacin—Skin disorder—Doxorubicin—ovarian cancer	4.19e-05	0.000199	CcSEcCtD
Ciprofloxacin—Paraesthesia—Epirubicin—ovarian cancer	4.19e-05	0.000198	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Doxorubicin—ovarian cancer	4.17e-05	0.000198	CcSEcCtD
Ciprofloxacin—Dyspnoea—Epirubicin—ovarian cancer	4.16e-05	0.000197	CcSEcCtD
Ciprofloxacin—Somnolence—Epirubicin—ovarian cancer	4.15e-05	0.000196	CcSEcCtD
Ciprofloxacin—Anorexia—Doxorubicin—ovarian cancer	4.12e-05	0.000195	CcSEcCtD
Ciprofloxacin—Nausea—Docetaxel—ovarian cancer	4.11e-05	0.000195	CcSEcCtD
Ciprofloxacin—Dyspepsia—Epirubicin—ovarian cancer	4.11e-05	0.000194	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	4.07e-05	0.00325	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	4.07e-05	0.00325	CbGpPWpGaD
Ciprofloxacin—Decreased appetite—Epirubicin—ovarian cancer	4.06e-05	0.000192	CcSEcCtD
Ciprofloxacin—Hypotension—Doxorubicin—ovarian cancer	4.04e-05	0.000191	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.03e-05	0.000191	CcSEcCtD
Ciprofloxacin—Fatigue—Epirubicin—ovarian cancer	4.02e-05	0.00019	CcSEcCtD
Ciprofloxacin—Constipation—Epirubicin—ovarian cancer	3.99e-05	0.000189	CcSEcCtD
Ciprofloxacin—Pain—Epirubicin—ovarian cancer	3.99e-05	0.000189	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.93e-05	0.000186	CcSEcCtD
Ciprofloxacin—Insomnia—Doxorubicin—ovarian cancer	3.91e-05	0.000185	CcSEcCtD
Ciprofloxacin—Paraesthesia—Doxorubicin—ovarian cancer	3.88e-05	0.000184	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	3.87e-05	0.00309	CbGpPWpGaD
Ciprofloxacin—Dyspnoea—Doxorubicin—ovarian cancer	3.85e-05	0.000182	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Epirubicin—ovarian cancer	3.85e-05	0.000182	CcSEcCtD
Ciprofloxacin—Somnolence—Doxorubicin—ovarian cancer	3.84e-05	0.000182	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Epirubicin—ovarian cancer	3.82e-05	0.000181	CcSEcCtD
Ciprofloxacin—Dyspepsia—Doxorubicin—ovarian cancer	3.8e-05	0.00018	CcSEcCtD
Ciprofloxacin—Decreased appetite—Doxorubicin—ovarian cancer	3.75e-05	0.000178	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.73e-05	0.000177	CcSEcCtD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	3.72e-05	0.00297	CbGpPWpGaD
Ciprofloxacin—Fatigue—Doxorubicin—ovarian cancer	3.72e-05	0.000176	CcSEcCtD
Ciprofloxacin—Urticaria—Epirubicin—ovarian cancer	3.71e-05	0.000176	CcSEcCtD
Ciprofloxacin—Pain—Doxorubicin—ovarian cancer	3.69e-05	0.000175	CcSEcCtD
Ciprofloxacin—Constipation—Doxorubicin—ovarian cancer	3.69e-05	0.000175	CcSEcCtD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	3.69e-05	0.00295	CbGpPWpGaD
Ciprofloxacin—Abdominal pain—Epirubicin—ovarian cancer	3.69e-05	0.000175	CcSEcCtD
Ciprofloxacin—Body temperature increased—Epirubicin—ovarian cancer	3.69e-05	0.000175	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	3.69e-05	0.00294	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MLH1—ovarian cancer	3.68e-05	0.00294	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—SKP2—ovarian cancer	3.64e-05	0.00291	CbGpPWpGaD
Ciprofloxacin—Feeling abnormal—Doxorubicin—ovarian cancer	3.56e-05	0.000168	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	3.54e-05	0.00282	CbGpPWpGaD
Ciprofloxacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.53e-05	0.000167	CcSEcCtD
Ciprofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	3.52e-05	0.00281	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	3.47e-05	0.00277	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	3.45e-05	0.00276	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Epirubicin—ovarian cancer	3.44e-05	0.000163	CcSEcCtD
Ciprofloxacin—Urticaria—Doxorubicin—ovarian cancer	3.43e-05	0.000162	CcSEcCtD
Ciprofloxacin—Abdominal pain—Doxorubicin—ovarian cancer	3.41e-05	0.000162	CcSEcCtD
Ciprofloxacin—Body temperature increased—Doxorubicin—ovarian cancer	3.41e-05	0.000162	CcSEcCtD
Ciprofloxacin—Asthenia—Epirubicin—ovarian cancer	3.35e-05	0.000159	CcSEcCtD
Ciprofloxacin—Pruritus—Epirubicin—ovarian cancer	3.3e-05	0.000156	CcSEcCtD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP1B1—ovarian cancer	3.26e-05	0.0026	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP1B1—ovarian cancer	3.21e-05	0.00256	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Epirubicin—ovarian cancer	3.19e-05	0.000151	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Doxorubicin—ovarian cancer	3.18e-05	0.000151	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.16e-05	0.00252	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	3.12e-05	0.00249	CbGpPWpGaD
Ciprofloxacin—Asthenia—Doxorubicin—ovarian cancer	3.1e-05	0.000147	CcSEcCtD
Ciprofloxacin—Dizziness—Epirubicin—ovarian cancer	3.09e-05	0.000146	CcSEcCtD
Ciprofloxacin—ABCB1—lymph node—ovarian cancer	3.06e-05	0.00871	CbGeAlD
Ciprofloxacin—Pruritus—Doxorubicin—ovarian cancer	3.06e-05	0.000145	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—CHEK2—ovarian cancer	2.98e-05	0.00238	CbGpPWpGaD
Ciprofloxacin—Vomiting—Epirubicin—ovarian cancer	2.97e-05	0.00014	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	2.96e-05	0.00236	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Doxorubicin—ovarian cancer	2.95e-05	0.00014	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	2.95e-05	0.00235	CbGpPWpGaD
Ciprofloxacin—Rash—Epirubicin—ovarian cancer	2.94e-05	0.000139	CcSEcCtD
Ciprofloxacin—Dermatitis—Epirubicin—ovarian cancer	2.94e-05	0.000139	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.93e-05	0.00234	CbGpPWpGaD
Ciprofloxacin—Headache—Epirubicin—ovarian cancer	2.92e-05	0.000138	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.87e-05	0.00229	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	2.86e-05	0.00229	CbGpPWpGaD
Ciprofloxacin—Dizziness—Doxorubicin—ovarian cancer	2.86e-05	0.000135	CcSEcCtD
Ciprofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	2.85e-05	0.00228	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.79e-05	0.00223	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CCND2—ovarian cancer	2.79e-05	0.00223	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—BRCA1—ovarian cancer	2.79e-05	0.00223	CbGpPWpGaD
Ciprofloxacin—Nausea—Epirubicin—ovarian cancer	2.77e-05	0.000131	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.77e-05	0.00221	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—NME2—ovarian cancer	2.75e-05	0.00219	CbGpPWpGaD
Ciprofloxacin—Vomiting—Doxorubicin—ovarian cancer	2.75e-05	0.00013	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	2.74e-05	0.00218	CbGpPWpGaD
Ciprofloxacin—Rash—Doxorubicin—ovarian cancer	2.72e-05	0.000129	CcSEcCtD
Ciprofloxacin—Dermatitis—Doxorubicin—ovarian cancer	2.72e-05	0.000129	CcSEcCtD
Ciprofloxacin—Headache—Doxorubicin—ovarian cancer	2.71e-05	0.000128	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.7e-05	0.00215	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	2.69e-05	0.00214	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	2.63e-05	0.0021	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	2.59e-05	0.00207	CbGpPWpGaD
Ciprofloxacin—Nausea—Doxorubicin—ovarian cancer	2.56e-05	0.000121	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—BRCA2—ovarian cancer	2.53e-05	0.00202	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	2.48e-05	0.00198	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CCNE1—ovarian cancer	2.45e-05	0.00195	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.44e-05	0.00194	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	2.42e-05	0.00193	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	2.4e-05	0.00192	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	2.4e-05	0.00192	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TYMS—ovarian cancer	2.4e-05	0.00192	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	2.35e-05	0.00188	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.3e-05	0.00184	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	2.27e-05	0.00181	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.24e-05	0.00179	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.19e-05	0.00175	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.19e-05	0.00175	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	2.19e-05	0.00175	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—BIRC5—ovarian cancer	2.16e-05	0.00172	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	2.12e-05	0.0017	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TERT—ovarian cancer	2.09e-05	0.00167	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.07e-05	0.00165	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	2e-05	0.0016	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2e-05	0.0016	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NME2—ovarian cancer	1.99e-05	0.00158	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	1.98e-05	0.00158	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	1.96e-05	0.00157	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	1.93e-05	0.00154	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	1.92e-05	0.00153	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.92e-05	0.00153	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—CASP3—ovarian cancer	1.92e-05	0.00153	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—IL2—ovarian cancer	1.91e-05	0.00153	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.9e-05	0.00152	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	1.88e-05	0.0015	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	1.86e-05	0.00149	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.84e-05	0.00147	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	1.84e-05	0.00147	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.84e-05	0.00147	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	1.83e-05	0.00146	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	1.8e-05	0.00144	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	1.8e-05	0.00144	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	1.8e-05	0.00144	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYTB—ovarian cancer	1.77e-05	0.00141	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	1.77e-05	0.00141	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	1.7e-05	0.00136	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	1.63e-05	0.0013	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	1.62e-05	0.00129	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.55e-05	0.00124	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PPP1CC—ovarian cancer	1.55e-05	0.00123	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—BRIP1—ovarian cancer	1.55e-05	0.00123	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.51e-05	0.00121	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.51e-05	0.00121	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NME2—ovarian cancer	1.5e-05	0.0012	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.49e-05	0.00119	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.45e-05	0.00116	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	1.45e-05	0.00115	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.42e-05	0.00113	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	1.42e-05	0.00113	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	1.35e-05	0.00108	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.34e-05	0.00107	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYTB—ovarian cancer	1.28e-05	0.00102	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	1.27e-05	0.00101	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CCND1—ovarian cancer	1.21e-05	0.000966	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.2e-05	0.000956	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NME2—ovarian cancer	1.2e-05	0.000955	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.12e-05	0.000893	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.12e-05	0.000893	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.12e-05	0.000891	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	1.09e-05	0.000866	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.06e-05	0.000847	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.04e-05	0.000831	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—YAP1—ovarian cancer	1.04e-05	0.000828	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.01e-05	0.00081	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	9.98e-06	0.000796	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MYC—ovarian cancer	9.7e-06	0.000775	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	9.69e-06	0.000773	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYTB—ovarian cancer	9.65e-06	0.000771	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	9.64e-06	0.00077	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	9.49e-06	0.000758	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	9.45e-06	0.000755	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.36e-06	0.000747	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NME2—ovarian cancer	9.23e-06	0.000737	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	9.2e-06	0.000735	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	9.11e-06	0.000727	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	8.88e-06	0.000709	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—FASN—ovarian cancer	8.46e-06	0.000675	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—BRIP1—ovarian cancer	8.44e-06	0.000674	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PPP1CC—ovarian cancer	8.44e-06	0.000674	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—SLC5A5—ovarian cancer	8.32e-06	0.000664	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.27e-06	0.00066	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—SLC2A1—ovarian cancer	8.04e-06	0.000641	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	8.02e-06	0.00064	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TP53—ovarian cancer	7.97e-06	0.000636	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYTB—ovarian cancer	7.71e-06	0.000615	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP1B1—ovarian cancer	7.7e-06	0.000615	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	7.59e-06	0.000606	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.53e-06	0.000601	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—YAP1—ovarian cancer	7.5e-06	0.000599	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	7.38e-06	0.000589	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	7.22e-06	0.000576	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	7.22e-06	0.000576	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	6.83e-06	0.000545	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	6.82e-06	0.000544	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	6.74e-06	0.000538	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—BRIP1—ovarian cancer	6.74e-06	0.000538	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—ABCB1—ovarian cancer	6.34e-06	0.000506	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	6.27e-06	0.0005	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—TYMS—ovarian cancer	6.23e-06	0.000497	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—FASN—ovarian cancer	6.11e-06	0.000488	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.06e-06	0.000484	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—SLC5A5—ovarian cancer	6.01e-06	0.00048	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYTB—ovarian cancer	5.95e-06	0.000475	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—SLC2A1—ovarian cancer	5.81e-06	0.000464	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—YAP1—ovarian cancer	5.66e-06	0.000452	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP1B1—ovarian cancer	5.57e-06	0.000445	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.2e-06	0.000415	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.2e-06	0.000415	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.12e-06	0.000409	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CAV1—ovarian cancer	5.02e-06	0.000401	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	4.94e-06	0.000394	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.91e-06	0.000392	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—FASN—ovarian cancer	4.61e-06	0.000368	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—ABCB1—ovarian cancer	4.59e-06	0.000366	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PIK3CG—ovarian cancer	4.57e-06	0.000365	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—SLC5A5—ovarian cancer	4.54e-06	0.000362	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—YAP1—ovarian cancer	4.52e-06	0.000361	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—TYMS—ovarian cancer	4.5e-06	0.00036	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.47e-06	0.000357	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—SLC2A1—ovarian cancer	4.38e-06	0.00035	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.2e-06	0.000335	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PIK3CD—ovarian cancer	4.02e-06	0.000321	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.93e-06	0.000314	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3.73e-06	0.000298	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—FASN—ovarian cancer	3.68e-06	0.000294	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CAV1—ovarian cancer	3.63e-06	0.00029	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.62e-06	0.000289	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PIK3CB—ovarian cancer	3.5e-06	0.00028	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.5e-06	0.000279	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—YAP1—ovarian cancer	3.49e-06	0.000278	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.43e-06	0.000274	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—TYMS—ovarian cancer	3.4e-06	0.000271	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.35e-06	0.000268	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PIK3CG—ovarian cancer	3.31e-06	0.000264	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PTEN—ovarian cancer	3.03e-06	0.000242	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.97e-06	0.000237	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.96e-06	0.000236	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PIK3CD—ovarian cancer	2.91e-06	0.000232	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—FASN—ovarian cancer	2.84e-06	0.000227	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.8e-06	0.000223	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.76e-06	0.000221	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CAV1—ovarian cancer	2.74e-06	0.000219	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—TYMS—ovarian cancer	2.71e-06	0.000217	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.7e-06	0.000216	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.59e-06	0.000207	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PIK3CB—ovarian cancer	2.53e-06	0.000202	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.49e-06	0.000199	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.3e-06	0.000183	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.19e-06	0.000175	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PTEN—ovarian cancer	2.19e-06	0.000175	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CAV1—ovarian cancer	2.19e-06	0.000175	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.14e-06	0.000171	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.13e-06	0.00017	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—TYMS—ovarian cancer	2.09e-06	0.000167	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.09e-06	0.000167	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.99e-06	0.000159	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.91e-06	0.000153	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.75e-06	0.00014	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—AKT1—ovarian cancer	1.74e-06	0.000139	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—CAV1—ovarian cancer	1.69e-06	0.000135	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PTEN—ovarian cancer	1.65e-06	0.000132	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.54e-06	0.000123	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.54e-06	0.000123	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.53e-06	0.000122	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.35e-06	0.000108	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PTEN—ovarian cancer	1.32e-06	0.000105	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—AKT1—ovarian cancer	1.26e-06	0.000101	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.18e-06	9.4e-05	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.17e-06	9.3e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PTEN—ovarian cancer	1.02e-06	8.12e-05	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—AKT1—ovarian cancer	9.52e-07	7.6e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	9.3e-07	7.43e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—AKT1—ovarian cancer	7.6e-07	6.07e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.18e-07	5.73e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—AKT1—ovarian cancer	5.86e-07	4.68e-05	CbGpPWpGaD
